FIELD: medicine. SUBSTANCE: essence of this method resides in administering Ringer's solution, polyglucin, diphenylhydramine hydrochloride, analginum, pyridoxine solution, glucose solution, procaine hydrochloride, ascorbic acid, strophanthin, hemodese, euphylline, plasma, contrical, and heparin. Disclosed method is distinguished from prior art in that it prescribes additionally administering mildronate, clofelin, thrental and rhelanium, administering about 300 to 500 ml Ringer's solution, about 300 to 500 ml polyglucin, 1 to 3 ml 1-percent solution of diphenylhydramine hydrochloride, 1 to 3 ml 50-percent solution of analginum, 1 to 3 ml 2.5-percent solution of pyridoxine, 300 to 500 ml 5-percent solution of glucose with 75 to 125 ths units of contrical, 300 to 500 ml of rheopolyglucin with 3 to 5 ml thrental, and 4 to 6 ml 10-percent solution of mildronate, slowly dropwise carrying out infusion of about 300 to 500 ml of glucose into patient's central vein, at the same time slowly dropwise infusing about 300 to 500 ml of 5-percent glucose solution and about 0.5 to 1.5 ml of 0.01-percent of clofelin into peripheral vein after positive central vein pressure has been attained, at the same time infusing about 300 to 500 ml 10-percent glucose solution, 12 units of insulin, about 4 to 6 ml of 5-percent solution of ascorbic acid, 150 to 250 ml of 5-percent glucose solution, about 150 to 250 ml of 0.25-percent procaine hydrochloride, 10 to 15 ml of 2.4-percent euphylline solution, about 0.5 to 1.0 ml of 0.05-percent strophanthin solution, about 1 to 2 ml of 0.5-percent rhelanium solution, about 300 to 500 ml hemodese solution, about 750 to 850 ml of plasma, and about 30 to 40 ths units per day of heparin into central vein during 4 to 6 h, and after patient's going out of shock, intramuscularly administering about 0.5 to 1.5 ml of clofelin three times a day during 72 to 120 h and intravenously administering about 4 to 6 ml of mildronate during fourteen days. EFFECT: greater intensity of therapy of burn disease and lower rate of side effects.
Authors
Dates
1995-07-20—Published
1992-07-08—Filed